Next-Generation Cellular Therapeutics

H-CYTE is developing a pipeline of next-generation cellular therapies to meet the needs of patients with a variety of diseases and chronic health conditions. With a focus on evidence-based medicine, innovation, and meaningful patient outcomes, we aim to become a leading biotech company in the field of regenerative medicine.

Learn About H-CYTE

Lung Health Institute

The Lung Health Institute offers patients suffering from chronic lung conditions an innovative therapy that targets the source of the symptoms and may help improve overall lung health.

Learn More

Who Is H-CYTE?

H-CYTE is a medical biosciences company focused in the field of regenerative medicine. Our mission is to become a leader in next-generation, cellular therapeutics for the treatment of chronic health conditions.

H-CYTE aims to be a leading biotech company focused on innovation, safe and efficacious products, FDA-approved products and meaningful patient outcomes. With a focus on evidence-based medicine, H-CYTE is working to begin clinical research and development of a diverse pipeline of next-generation regenerative therapeutics to meet the needs of patients with a variety of diseases and chronic health conditions.

Our Leadership Team

Tanya Rhodes, PhD

Interim CEO & Chief Technology Officer

Jeremy Daniel

Chief Financial Officer

Learn More About Our Leadership Team